MEA IVF Tools and Techniques Market is expected to reach the market valuation of US$ 3.164.7 million by 2027 expanding at a reasonable CAGR of 16.3% during the forecast period (2021-2027) from US$ 1,989.7 million in 2019. IVF is the procedure which is used to help with fertility or prevent genetic problems and assist with the conception of a child. 6-7 million couples in the 20-40 age group in Middle East suffer from infertility, as reveled by UAE Federal National Council (FNC).

The demand of IVF tools and techniques in MEA region is propelling on account of factors such as are governmental support, partial or full insurance coverage of treatment cost and social and religious values of childbearing and the role of children in family stability. The infertility rate in the middle east and African countries such as UAE, Saudi Arabia, Kuwait, Oman and other are quite significant across the globe. According to the World Bank data, the birth rate in the Middle east and Africa region has significantly dropped in past few years, from an average of 3.1 in 2000 to just 2.7 child in 2019. Also, women in Dubai seeking treatment per year could nearly double, from 5,975 in 2015 to 9,139 by 2030, as revealed by DHA. Therefore, the development of IVF clinic in Middle East region is faster than the rest of the world and even more than European and North American countries. As per per U.S. National Library of Medicine, more than 70 IVF centers are active in Iran that more than 25 centers of them are in capital or more than 110 centers are active in Turkey and Emirates, Egypt, Jordan, and Saudi Arabia.

Download Free Sample of this Report - https://univdatos.com/request_form/form/419

COVID19 is a global crisis that has significantly affected the field of infertility and IVF practice. This also includes risk groups such as pregnant women and neonates. As COVID-19 cases are on the rapid rise in the Middle East and African region, the countries across region went through a strict lockdown for months and couple of days, IVF clinics had to shut down and all assisted reproductive process was postponed. Many patients, who were undergoing treatment, had to cancel their plans midway. Literally 50% of this industry’s clinics shut down for two months so far in 2020. Moreover, The covid-19 pandemic has significantly disrupted the fertility tourism industry with strict travel restrictions being imposed by governments around the world in addition to postponed procedures for elective medical requirements. The market is likely to witness a gradual recovery through 2021, as governments are relaxing lockdown restrictions in a bid to restart economic activity.

Request To Download Sample of this Strategic Report - https://univdatos.com/request_form/form/419

Based on Gender Type, the market is fragmented into Male, Female and Both. The Female segment dominated the market in 2020 accounted for 60.7% and is anticipated to maintain its dominance during the forecast period owing to the factors such as decreasing fertility rate due to women’s choice of late marriages, an aspiration to be economically independent, labor force participation rates . Decreased ovarian reserves and ovulation disorders, Tubal damage, polycystic ovary syndrome, endometriosis and unexplained infertility are some of the cause that contributes around 46%, 23%, 20% and 9% respectively.

Request for full report - https://univdatos.com/request_form/form/419

Based on the Tools Type, the market is mainly fragmented into Imaging Systems, Sperm Separation Syatems, Ovum Aspiration Systems, Imcubators& micromanipulator system, Cryo systems and others. The ovum aspiration systems segment dominated the market in 2020 and gathered 30.9% in 2020. Moreover, the segment is anticipated to maintain its dominance during the analyzed period. The market of the this segment is witnessing an up-tick on account of the soaring growth in the disposable income amongst individuals which has resulted in the high adoption rate for in vitro fertilization procedures which is expected to subsequently improve the demand rates for ovum aspiration pumps.

Based on the Techniques Type, the market is mainly fragmented into Intracytoplasmic sperm injection (ICSI), Pre-Implantation Genetic Diagnosis (PGD) and frozen embryo transfer/ replacement. The Intra-Cytoplasmic Sperm Injection (ICSI) segment dominated the market in 2020 and gathered 86.2% in 2020. Moreover, the segment is anticipated to maintain its dominance during the analyzed period as well. Howwver, the frozen embryo transfer/ replacement is expected to witness the highest CAGR in the forthcoming years due to governmment’s support and approval for the egg, sperm and embryo freezing , which would cut the cost by 80%.

Request for Sample of the report browses through – https://univdatos.com/request_form/form/419

Additionally, the report provides detailed initiatives that are being taken in the field of IVF Tools and Techniquess. The market is classified into distinct countries including UAE, Saudi Arabia, Oman, Kuwait, Nigeria, South Africa and Rest of MEA has been conducted. UAE dominated the market with 32.1% in 2020 owing to the surging investment in the industry, rising medical tousrim for IVF treatment. IN UAE, Medical tourism accounts for 10% to 15 % of the IVF patient volume. Motoever, UAE's Gulf Capital reveals major IVF expansion plan after US$100m deal in 2020.

MEA IVF Tools and Techniques Market Segmentation

Market Insight, by Gender Type

· Male

· Female

· Both

Market Insight, by Tools Type

· Imaging Systems

· Sperm Separation Systems

· Ovum Aspirations Pumps

· Incubators, Micromanipulator Systems

· Cryosystems

· Others (Gas Analyzers, Laser System, Etc.)

Market Insight, by Techniques Type

· Intra-Cytoplasmic Sperm Injection (ICSI)

· Pre-Implantation Genetic Diagnosis (PGD)

· Frozen Embryo Transfer/Replacement (FET/FER)

Market Insight, by End-User Type

· Fertility & Surgical Centres

· Hospitals

· Research Clinics

Market Insight, by Country

· UAE

· Saudi Arabia

· Oman

· Kuwait

· Nigeria

· South Africa

· Rest of MEA

Top Company Profiles

· Cooper surgical, Inc

· Vitrolife

· Cook Medical, Inc.

· Irvine Scientific

· Thermo Fisher Scientific, Inc.

· EMD Serono, Inc.

· Genea Limited

· Esco Micro Pte. Limited,

· IVFtech Aps

· The Bakers Company Inc.